ResearcherTongji HospitalActive in the last 2 years
Cheng Tian
Matched on ORCID iD 0000-0003-4046-2288; OpenAlex author ID A5042329149. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- YY1 Lactylation Elicits CARD9 Deficiency in Dendritic Cells Promoting Pancreatic Cancer Immune Escape. First author DOI 10.7150/ijbs.131102↗
- REG3A promotes gemcitabine resistance in pancreatic cancer via the GPR54/ARRB2/ERK1/2 ligand-directed signaling pathway. Co-author DOI 10.1016/j.bcp.2025.117322↗
- The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB … Co-author DOI 10.1016/j.clim.2022.109217↗
- CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport. Co-author DOI 10.1080/2162402x.2023.2204015↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Senlin Li · 4 shared papers, 2023–2026 · strength 0.89
- Paper YY1 Lactylation Elicits CARD9 Deficiency in Dendritic Cells Promoting Pancreatic Cancer Immune Escape. DOI 10.7150/ijbs.131102↗
- Paper REG3A promotes gemcitabine resistance in pancreatic cancer via the GPR54/ARRB2/ERK1/2 ligand-directed signaling pathway. DOI 10.1016/j.bcp.2025.117322↗
- Paper The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic c… DOI 10.1016/j.clim.2022.109217↗
- Ming Xiang · 4 shared papers, 2023–2026 · strength 0.89
- Paper YY1 Lactylation Elicits CARD9 Deficiency in Dendritic Cells Promoting Pancreatic Cancer Immune Escape. DOI 10.7150/ijbs.131102↗
- Paper REG3A promotes gemcitabine resistance in pancreatic cancer via the GPR54/ARRB2/ERK1/2 ligand-directed signaling pathway. DOI 10.1016/j.bcp.2025.117322↗
- Paper The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic c… DOI 10.1016/j.clim.2022.109217↗
- Lingyan Ding · 1 shared paper, 2026 · strength 0.30
- Mengzhu Zheng · 1 shared paper, 2026 · strength 0.30
- Jia Liu · 1 shared paper, 2025 · strength 0.24
- Qing Li · 1 shared paper, 2025 · strength 0.24
- Qing Li · 1 shared paper, 2023 · strength 0.18
- Ferdinando Nicoletti · 1 shared paper, 2023 · strength 0.18
- Qian Liu · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.